Anti-LGR5 & EGFR Antibody (Petosemtamab)
Catalog No.
F1411
Anti-LGR5 & EGFR Antibody (Petosemtamab)
Featured Products
Petosemtamab (MCLA 158) is an anti-EGFR (Kd : 0.22 nM) and antiLGR5 (Kd 0.86 nM) monoclonal antibody (mAb). Petosemtamab leads toEGFR Signal transduction blockade and receptor degradation. Petosemtamab can be used in the study of solid tumors such as head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal cancer (CRC).
145.97 kDa
Dry ice
2213450-26-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
MCLA-158, MCLA158
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00533 & O75473
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
LGR5 & EGFR
Please avoid freeze-thaw cycles.